Clinical Trials Logo

Clinical Trial Summary

The investigators want to demonstrate in a prospective, randomized trial including 350 patients undergoing cranial surgery that the use of L-PRF is non-inferior to classical fibrin sealants.


Clinical Trial Description

The investigators want to demonstrate in a prospective, randomized trial including 350 patients undergoing cranial surgery that the use of L-PRF is non-inferior to classical fibrin sealants.

Approximately 350 patients undergoing cranial surgery will be enrolled in this randomized, controlled, single-blinded monocenter study to evaluate the safety and effectiveness of autologous blood-derived products (L-PRF and fibrinogen) compared to the fibrin sealants as an adjunct for dural repair (= primary objective).

The investigators will also evaluate if the use of L-PRF obviates the need for the use of other autologous grafts (e.g. muscle/fat), commercial collagen-based products (e.g. Tachosil) or articifial dura (=secondary objective). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03812120
Study type Interventional
Source Universitaire Ziekenhuizen Leuven
Contact Tom Theys, Prof
Phone 003216344290
Email tom.theys@uzleuven.be
Status Recruiting
Phase N/A
Start date December 1, 2018
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT03910374 - Role of Leukocyte- and Platelet-Rich Fibrin Membranes in Endoscopic Endonasal Skull Base Reconstruction N/A